Southern Research Drug DevelopmentContact Us
Southern Research Drug Development provides commercial and government clients with a wide variety of nonclinical and clinical trial support services. We offer an array of studies including both in vitro and in vivo testing of small molecule compounds, vaccines, biologics and other test articles in therapeutic areas, such as infectious disease, CNS and cancer.
Our nationally recognized team of dedicated individuals provides expertise and services spanning from basic research to advanced studies under FDA GLP regulations.
Drug Development Services
How To Work With Us
As a CRO service provider, Southern Research’s Drug Development division has a straightforward business model. Contact our business development representative by clicking here. A confidentiality disclosure agreement will be initiated (your agreement or ours) to facilitate detailed discussions around your specific needs. One of our subject matter experts will be brought into the discussion to ensure we have a comprehensive understanding of your project. A proposal will then be prepared, outlining the tasks to be accomplished, along with a budget and timeline. Upon acceptance of the proposal, a contract will be provided to establish the legal framework for the project.
Drug Development News
Southern Research reproductive toxicology scientist Paul Bushdid, Ph.D., is working to develop a new, cost-efficient laboratory test to evaluate hazards to unborn children posed by potential medicines, chemicals and other […]
Southern Research has been awarded two contracts from the Biomedical Advanced Research and Development Authority (BARDA), which is a division of the U.S. Department of Health and Human Services’ Office […]
A Southern Research scientist says a new generation of antiviral therapies is urgently needed against hepatitis B, a chronic disease affecting 240 million people whose cure has proved elusive. Raj […]